135 related articles for article (PubMed ID: 35001057)
1. Infantile Stage M Neuroblastoma With 11q Deletion, Mimicking Stage MS.
Yoshimoto Suzuki Y; Yamanaka J; Miyazaki O; Nozawa K; Ohira M; Kamijo T; Shichino H
J Pediatr Hematol Oncol; 2022 Apr; 44(3):e779-e781. PubMed ID: 35001057
[TBL] [Abstract][Full Text] [Related]
2. An infant with neuroblastoma and MYCN amplification found through mass screening.
Taga T; Okamoto N; Hisano T; Tanaka T; Shimada M; Okabe H; Shimada H; Ohta S
J Pediatr Hematol Oncol; 1998; 20(5):486-8. PubMed ID: 9787326
[TBL] [Abstract][Full Text] [Related]
3. Defining Risk Factors for Chemotherapeutic Intervention in Infants With Stage 4S Neuroblastoma: A Report From Children's Oncology Group Study ANBL0531.
Twist CJ; Naranjo A; Schmidt ML; Tenney SC; Cohn SL; Meany HJ; Mattei P; Adkins ES; Shimada H; London WB; Park JR; Matthay KK; Maris JM
J Clin Oncol; 2019 Jan; 37(2):115-124. PubMed ID: 30444686
[TBL] [Abstract][Full Text] [Related]
4. Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11q deletion in tumors lacking MYCN amplification.
Plantaz D; Vandesompele J; Van Roy N; Lastowska M; Bown N; Combaret V; Favrot MC; Delattre O; Michon J; BĂ©nard J; Hartmann O; Nicholson JC; Ross FM; Brinkschmidt C; Laureys G; Caron H; Matthay KK; Feuerstein BG; Speleman F
Int J Cancer; 2001 Mar; 91(5):680-6. PubMed ID: 11267980
[TBL] [Abstract][Full Text] [Related]
5. Significance of chromosome 1p loss of heterozygosity in neuroblastoma.
Maris JM; White PS; Beltinger CP; Sulman EP; Castleberry RP; Shuster JJ; Look AT; Brodeur GM
Cancer Res; 1995 Oct; 55(20):4664-9. PubMed ID: 7553646
[TBL] [Abstract][Full Text] [Related]
6. Distinct cytogenetic pathways of advanced-stage neuroblastoma tumors, detected by spectral karyotyping.
Stark B; Jeison M; Bar-Am I; Glaser-Gabay L; Mardoukh J; Luria D; Feinmesser M; Goshen Y; Stein J; Abramov A; Zaizov R; Yaniv I
Genes Chromosomes Cancer; 2002 Jul; 34(3):313-24. PubMed ID: 12007192
[TBL] [Abstract][Full Text] [Related]
7. Differences in Genomic Profiles and Outcomes Between Thoracic and Adrenal Neuroblastoma.
Oldridge DA; Truong B; Russ D; DuBois SG; Vaksman Z; Mosse YP; Diskin SJ; Maris JM; Matthay KK
J Natl Cancer Inst; 2019 Nov; 111(11):1192-1201. PubMed ID: 30793172
[TBL] [Abstract][Full Text] [Related]
8. Deletions in chromosome arms 3p and 11q are new prognostic markers in localized and 4s neuroblastoma.
Spitz R; Hero B; Ernestus K; Berthold F
Clin Cancer Res; 2003 Jan; 9(1):52-8. PubMed ID: 12538451
[TBL] [Abstract][Full Text] [Related]
9. Bilateral adrenal neuroblastoma is different.
Pederiva F; Andres A; Sastre A; Alves J; Martinez L; Tovar JA
Eur J Pediatr Surg; 2007 Dec; 17(6):393-6. PubMed ID: 18072022
[TBL] [Abstract][Full Text] [Related]
10. Favorable histology, MYCN-amplified 4S neonatal neuroblastoma.
Chan EL; Harris RE; Emery KH; Gelfand MJ; Collins MH; Gruppo RA
Pediatr Blood Cancer; 2007 Apr; 48(4):479-82. PubMed ID: 16333837
[TBL] [Abstract][Full Text] [Related]
11. Gain of distal chromosome arm 17q is not associated with poor prognosis in neuroblastoma.
Spitz R; Hero B; Ernestus K; Berthold F
Clin Cancer Res; 2003 Oct; 9(13):4835-40. PubMed ID: 14581355
[TBL] [Abstract][Full Text] [Related]
12. Risks and benefits of ending of mass screening for neuroblastoma at 6 months of age in Japan.
Tajiri T; Souzaki R; Kinoshita Y; Tanaka S; Koga Y; Suminoe A; Matsuzaki A; Hara T; Taguchi T
J Pediatr Surg; 2009 Dec; 44(12):2253-7. PubMed ID: 20006005
[TBL] [Abstract][Full Text] [Related]
13. Clinical Significance of Segmental Chromosomal Aberrations in Patients with Neuroblastoma: First Report in Korean Population.
Lim H; Son MH; Hyun JK; Cho HW; Ju HY; Lee JW; Yoo KH; Sung KW; Koo HH
J Korean Med Sci; 2020 Apr; 35(14):e82. PubMed ID: 32281311
[TBL] [Abstract][Full Text] [Related]
14. Concordance for neuroblastoma in monozygotic twins: case report and review of the literature.
Tajiri T; Souzaki R; Kinoshita Y; Tanaka S; Koga Y; Suminoe A; Hara T; Kohashi K; Oda Y; Masumoto K; Ohira M; Nakagawara A; Taguchi T
J Pediatr Surg; 2010 Dec; 45(12):2312-6. PubMed ID: 21129536
[TBL] [Abstract][Full Text] [Related]
15. Constitutional 11q14-q22 chromosome deletion syndrome in a child with neuroblastoma MYCN single copy.
Passariello A; De Brasi D; Defferrari R; Genesio R; Tufano M; Mazzocco K; Capasso M; Migliorati R; Martinsson T; Siani P; Nitsch L; Tonini GP
Eur J Med Genet; 2013 Nov; 56(11):626-34. PubMed ID: 24035971
[TBL] [Abstract][Full Text] [Related]
16. Evolution of unbalanced gain of distal chromosome 2p in neuroblastoma.
Stallings RL; Carty P; McArdle L; Mullarkey M; McDermott M; O'Meara A; Ryan E; Catchpoole D; Breatnach F
Cytogenet Genome Res; 2004; 106(1):49-54. PubMed ID: 15218241
[TBL] [Abstract][Full Text] [Related]
17. Quantitative real-time PCR for quick simultaneous determination of therapy-stratifying markers MYCN amplification, deletion 1p and 11q.
Boensch M; Oberthuer A; Fischer M; Skowron M; Oestreich J; Berthold F; Spitz R
Diagn Mol Pathol; 2005 Sep; 14(3):177-82. PubMed ID: 16106200
[TBL] [Abstract][Full Text] [Related]
18. A case of adrenal haemorrhage after minor trauma in a young child: think of neuroblastoma.
Normand C; Leblond P; Mazingue F; Nelken B; Defachelles AS; Bonnevalle M
Eur J Pediatr Surg; 2006 Oct; 16(5):365-8. PubMed ID: 17160786
[TBL] [Abstract][Full Text] [Related]
19. Loss in chromosome 11q identifies tumors with increased risk for metastatic relapses in localized and 4S neuroblastoma.
Spitz R; Hero B; Simon T; Berthold F
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3368-73. PubMed ID: 16740759
[TBL] [Abstract][Full Text] [Related]
20. Successful liver transplantation in an infant with stage 4S(M) neuroblastoma.
Steele M; Jones NL; Ng V; Kamath B; Avitzur Y; Chami R; Cutz E; Fecteau A; Baruchel S
Pediatr Blood Cancer; 2013 Mar; 60(3):515-7. PubMed ID: 23152322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]